In Vitro Diagnostics Quality Control Market is expected to exhibit a strong 3.3% CAGR During 2017-2022

0
63

According to Transparency Market Research, The Global In Vitro Diagnostics Quality Control Market is likely to rise to a valuation of US$710.8 mn by the end of 2017 and further rise to US$837 mn by the end of 2022. The in vitro diagnostics quality control market is expected to exhibit a strong 3.3% CAGR over the 2017-2022 forecast period. The improved accuracy in diagnoses provided by in vitro diagnostics has made it important in the healthcare sector, making the in vitro diagnostics quality control market crucial in terms of maintaining the advantage provided by in vitro diagnostics to physicians. The rising demand for more accurate diagnoses in the healthcare sector is thus likely to remain a key driver for the global in vitro diagnostics quality control market over the 2017-2022 forecast period.

The rising number of accredited clinical laboratories in emerging regions is likely to remain a prime driver for the global in vitro diagnostics quality control market in the coming years. Accredited clinical laboratories have been a constant need for the in vitro diagnostics quality control market and their lack in developing regions has been one of its key restraints. Thus, the growing government support and private investment in the development of medical infrastructure in emerging regions such as Asia Pacific except Japan, Latin America, and the Middle East is likely to be a major driver for the global in vitro diagnostics quality control market over the 2017-2022 forecast period. Asia Pacific except Japan is likely to play a crucial role in the development of the global in vitro diagnostics quality control market in the coming years. The APEJ market for in vitro diagnostics quality controls is set to exhibit a robust 3.5% CAGR over the 2017-2022 forecast period, rising to a valuation of US$136 mn by the end of 2022. North America is likely to dominate the global in vitro diagnostics quality controls market in the coming years due to the widespread availability of advanced medical infrastructure in the region and the presence of several leading players in the healthcare and medical device sectors, which has enabled steady development of the in vitro diagnostics quality controls market.

Key players in the global in vitro diagnostics quality control market include Abbott Laboratories, Bio-Rad Laboratories Inc., Helena Laboratories, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Diagnostics, Seracare Life Sciences Inc., Siemens Healthineers, Sun Diagnostics LLC, Thermo Fisher Scientific Inc., Sysmex Corporation, and Quantimetrix Corporation.

Request to view Sample Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33194

Leave a Reply